Reneo Reveals $50m Series A, Mitochondrial Disease Development Plans

 
• By Mandy Jackson
  
Hand man doing finances and calculate on desk about cost at home office.
Reneo will run three trials with its $50m in series A cash. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from Business